Literature DB >> 7093883

Detection and follow-up of carcinoma of the urinary bladder by flow cytometry.

F A Klein, H W Herr, P C Sogani, W F Whitmore, M R Melamed.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7093883     DOI： 10.1002/1097-0142(19820801)50:3<389::aid-cncr2820500302>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

Review 1.  Carcinoma in situ and treatment options.

Authors:  M Erton; Y Ilker
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

2.  Neoplastic invasion of the connective stalks in transitional cell papillary tumors (TCPT) of the bladder.

Authors:  A Tommasini-Degna; R Negri
Journal:  Urol Res       Date:  1987

3.  Flow cytometric DNA analysis of parathyroid glands. Relationship between nuclear DNA and pathologic classifications.

Authors:  L S Bowlby; L E DeBault; S R Abraham
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

4.  Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience.

Authors:  C Billerey; B Lamy; H Bittard; S Rozan; J P Carbillet
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

5.  DNA analysis and parathyroid pathology.

Authors:  B K Shenton; H Ellis; I D Johnston; J R Farndon
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

6.  Phase I/II trial of intravesical methotrexate for superficial bladder tumors.

Authors:  C N Sternberg; A Yagoda; N H Bander; W F Whitmore; J L Huffman; M Fleisher; M Melamed; M P Fanucchi; P Hollander; E D Vaughan
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer.

Authors:  A Frassoldati; M Federico; F Barbieri; M Brausi; C Pollastri; G Berri; G Castagnetti; P P Palladini; V Silingardi
Journal:  Med Oncol Tumor Pharmacother       Date:  1991
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.